Page 111 - Read Online
P. 111

Page 16 of 20                                                Orekhov et al. Vessel Plus 2019;3:10  I  http://dx.doi.org/10.20517/2574-1209.2019.04

               40.  Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, et al. Phosphorylation of the Stat1 transactivation domain is required for
                   full-fledged IFN-gamma-dependent innate immunity. Immunity 2003;19:793-802.
               41.  Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity 2000;13:795-804.
               42.  Zhao W, Cha EN, Lee C, Park CY, Schindler C. Stat2-dependent regulation of MHC class II expression. J Immunol 2007;179:463-71.
               43.  Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1
                   transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci USA 2006;103:15136-41.
               44.  Ryzhakov G, Eames HL, Udalova IA. Activation and function of interferon regulatory factor 5. J Interferon Cytokine Res 2015;35:71-8.
               45.  Chang Foreman HC, Van Scoy S, Cheng TF, Reich NC. Activation of interferon regulatory factor 5 by site specific phosphorylation.
                   PLoS One 2012;7:e33098.
               46.  Ren J, Chen X, Chen ZJ. IKKβ is an IRF5 kinase that instigates inflammation. Proc Natl Acad Sci USA 2014;111:17438-43.
               47.  Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and
                   polarization: new molecules and patterns of gene expression. J Immunol 2006;177:7303-11.
               48.  Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J, et al. Essential role of interferon regulatory factor 3 in direct activation of RANTES
                   chemokine transcription. Mol Cell Biol 1999;19:959-66.
               49.  Sgarbanti M, Marsili G, Remoli AL, Stellacci E, Mai A, et al. IκB kinase ε targets interferon regulatory factor 1 in activated T
                   lymphocytes. Mol Cell Biol 2014;34:1054-65.
               50.  Carey M. The enhanceosome and transcriptional synergy. Cell 1998;92:5-8.
               51.  Nhu QM, Cuesta N, Vogel SN. Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in
                   murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2). J Endotoxin Res 2006;12:285-95.
               52.  Elser B, Lohoff M, Kock S, Giaisi M, Kirchhoff S, et al. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity
                   2002;17:703-12.
               53.  Laricchia-Robbio L, Tamura T, Karpova T, Sprague BL, McNally JG, et al. Partner-regulated interaction of IFN regulatory factor 8 with
                   chromatin visualized in live macrophages. Proc Natl Acad Sci USA 2005;102:14368-73.
               54.  Sharf R, Azriel A, Lejbkowicz F, Winograd SS, Ehrlich R, et al. Functional domain analysis of interferon consensus sequence binding
                   protein (ICSBP) and its association with interferon regulatory factors. J Biol Chem 1995;270:13063-9.
               55.  Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice
                   with a targeted mutation of the ICSBP gene. Cell 1996;87:307-17.
               56.  Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that
                   ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol 2007;179:26-30.
               57.  Chang TH, Xu S, Tailor P, Kanno T, Ozato K. The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1
                   switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation. J Immunol 2012;189:3548-56.
               58.  Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2,
                   bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989;58:729-39.
               59.  Han KJ, Jiang L, Shu HB. Regulation of IRF2 transcriptional activity by its sumoylation. Biochem Biophys Res Commun
                   2008;372:772-8.
               60.  Cuesta N, Salkowski CA, Thomas KE, Vogel SN. Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2. J Immunol
                   2003;170:5739-47.
               61.  Cuesta N, Nhu QM, Zudaire E, Polumuri S, Cuttitta F, et al. IFN regulatory factor-2 regulates macrophage apoptosis through a
                   STAT1/3- and caspase-1-dependent mechanism. J Immunol 2007;178:3602-11.
               62.  Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, et al. Crucial role of interferon consensus sequence binding protein, but
                   neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J Exp Med 1997;185:921-
                   31.
               63.  Klune JR, Dhupar R, Kimura S, Ueki S, Cardinal J, et al. Interferon regulatory factor-2 is protective against hepatic ischemia-
                   reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2012;303:G666-73.
               64.  Salminen A, Kaarniranta K, Hiltunen M, Kauppinen A. Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic
                   regulation of inflammation and the aging process. J Mol Med (Berl) 2014;92:1035-43.
               65.  Dahle Ø, Kumar A, Kuehn MR. Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at
                   target genes. Sci Signal 2010;3:ra48.
               66.  Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood
                   2009;114:3244-54.
               67.  Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science
                   2003;300:1527-8.
               68.  Tugal D, Liao X, Jain MK. Transcriptional control of macrophage polarization. Arterioscler Thromb Vasc Biol 2013;33:1135-44.
               69.  Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL. Components of a Stat recognition code: evidence for two layers of molecular
                   selectivity. Immunity 1995;2:689-97.
               70.  Ohmori Y, Hamilton TA. STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J Biol
                   Chem 1988;273:29202-9.
               71.  Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, et al. Essential role of Stat6 in IL-4 signalling. Nature 1996;380:627-30.
               72.  Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol
   106   107   108   109   110   111   112   113   114   115   116